ImmunoServ
ImmunoServ is a Cardiff-based contract research organisation specialising in immunology-focused laboratory services, assay kit development and immune monitoring. The company provides laboratory testing (T cell, antibody and cellular assays), remote capillary blood sampling solutions, assay kit manufacture and bespoke assay development, and collaborates with academic and public‑health partners on vaccine and infectious-disease projects. ImmunoServ holds ISO 9001 and Cyber Essentials certifications and reports multiple public-sector grants and awards supporting its R&D pipeline.
Industries
N/A
Nr. of Employees
small (1-50)
ImmunoServ
Cardiff Medicentre, Heath Park, Cardiff, CF14 4UJ, United Kingdom
Products
At‑Home Blood Collection Kit
A scalable capillary blood sampling kit containing lancets, collection microtainer, return envelope and instructions for remote self-collection and postal return; UKCA marked and UN3373 compliant.
Immuno‑T Laboratory Test Kit
A laboratory immunoassay kit containing lyophilised antigens and a complete ELISA workflow for standardized measurement of antigen-specific T cell responses from fresh blood samples.
At‑Home Blood Collection Kit
A scalable capillary blood sampling kit containing lancets, collection microtainer, return envelope and instructions for remote self-collection and postal return; UKCA marked and UN3373 compliant.
Immuno‑T Laboratory Test Kit
A laboratory immunoassay kit containing lyophilised antigens and a complete ELISA workflow for standardized measurement of antigen-specific T cell responses from fresh blood samples.
Services
Laboratory immune monitoring to measure T cell and antibody responses to SARS-CoV-2 and other pathogens to support clinical studies and population immunity projects.
Simultaneous quantification of multiple soluble biomarkers using bead-based multiplex platforms for research projects.
Cellular assays to enumerate cytokine-producing T cells or antibody-secreting B cells.
Multi-parameter immunophenotyping and functional flow cytometry, including intracellular cytokine staining, proliferation assays and bead arrays.
T-cell receptor sequencing and repertoire analysis to support immunotherapy development, biomarker discovery, and patient stratification.
HLA genotyping services to support immunogenetics in research and clinical studies.
Laboratory immune monitoring to measure T cell and antibody responses to SARS-CoV-2 and other pathogens to support clinical studies and population immunity projects.
Simultaneous quantification of multiple soluble biomarkers using bead-based multiplex platforms for research projects.
Cellular assays to enumerate cytokine-producing T cells or antibody-secreting B cells.
Multi-parameter immunophenotyping and functional flow cytometry, including intracellular cytokine staining, proliferation assays and bead arrays.
T-cell receptor sequencing and repertoire analysis to support immunotherapy development, biomarker discovery, and patient stratification.
HLA genotyping services to support immunogenetics in research and clinical studies.
Expertise Areas
- T cell immunoassays and immune monitoring
- Immunoassay kit development and scale-up
- Immunophenotyping by flow cytometry
- Multiplex biomarker quantification
Key Technologies
- Whole-blood IFN-γ release assay (ELISA readout)
- ELISA
- ELISpot / FluoroSpot
- Multi-colour flow cytometry
News & Updates
Peer‑reviewed Nature Communications paper reporting whole-blood T cell responses as a correlate of COVID-19 immunity; the research is cited in company materials.
Named winner in the Innovation, Science & Technology category at the 2025 St David Awards (national awards of Wales).
Awarded Innovate UK funding (Biomedical Catalyst) to develop a standardised T cell immunity test for Group A Streptococcus (Strep A).
Received a share of iiCON (UKRI) funding to develop and deploy a capillary blood T cell test for H5N1 avian influenza in a pilot population study.
Awarded follow-on funding from the Welsh Government to support R&D in T cell testing and investment in laboratory equipment and collaborations.
Won the Industry Judges Award at the MediWales Innovation Awards recognizing achievement in the Welsh life sciences sector.
Peer‑reviewed Nature Communications paper reporting whole-blood T cell responses as a correlate of COVID-19 immunity; the research is cited in company materials.
Named winner in the Innovation, Science & Technology category at the 2025 St David Awards (national awards of Wales).
Awarded Innovate UK funding (Biomedical Catalyst) to develop a standardised T cell immunity test for Group A Streptococcus (Strep A).
Received a share of iiCON (UKRI) funding to develop and deploy a capillary blood T cell test for H5N1 avian influenza in a pilot population study.
Awarded follow-on funding from the Welsh Government to support R&D in T cell testing and investment in laboratory equipment and collaborations.
Won the Industry Judges Award at the MediWales Innovation Awards recognizing achievement in the Welsh life sciences sector.